Wells Fargo initiated coverage of Ventyx Biosciences with an Overweight rating and $77 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VTYX:
- Ventyx Biosciences price target raised to $65 from $60 at Oppenheimer
- Ventyx Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
- Ventyx Biosciences provides update on Silicon Valley Bank financial exposure
- Ventyx Biosciences Provides Update on Silicon Valley Bank Financial Exposure
- Ventyx Biosciences price target raised to $54 from $35 at Canaccord